Particle.news
Download on the App Store

ISS Microgravity Reshapes Phage–Bacteria Coevolution, Revealing Mutations With Potential Against Resistant E. coli

Microgravity reshaped coevolution, producing receptor‑binding changes later shown to boost activity against drug‑resistant UTI E. coli in lab tests.

Overview

  • University of Wisconsin–Madison researchers directly compared T7 phage infecting E. coli on Earth and aboard the International Space Station.
  • Phage infection in space showed an initial delay, consistent with altered fluid mixing and reduced encounter rates under microgravity.
  • Whole-genome sequencing found that both the phages and the bacteria evolved mutations in space that differed markedly from Earth controls.
  • Deep mutational scanning pinpointed microgravity-associated changes in the T7 receptor binding protein that shifted host targeting.
  • ISS-derived variants demonstrated increased activity against T7-resistant, UTI-causing E. coli in Earth experiments, with the PLOS Biology paper presenting this as a proof-of-concept for biosafety monitoring and phage engineering.